Abstract
UK is the first country to implement symptom triggered testing for suspected ovarian cancer (OC) following guidance from National Institute of Clinical Excellence in 2011. We evaluated its impact on cancer outcomes and implications on clinical practice. This is a cohort study and we analysed data for all new urgent referrals for suspected OC from two large teaching hospitals using a prospectively collected electronic referral database, supplemented with clinical data from electronic records. We evaluated outcomes prior to (2011) and after (2013) implementation of guidance to evaluate stage shift, referrals workload and surgical procedures generated. Secondary care received 2185 new referrals from primary care for women with suspected gynaecological cancer in post guideline cohort. Of these, 217 women were referred for suspected OC. 90% of primary care referrals were not compliant with guidance. Following implementation of guidance, more women with OC were diagnosed through urgent referral (rapid access clinics): Almost double, 21 of the total 67 (31.34%) OCs in 2013 (post guidance) in comparison to only 11 of 69 OCs (15.94%) were diagnosed in 2011 (pre guidance) through urgent referrals, p=0.03. The predictive value of detectin...Continue Reading
References
Jun 12, 2003·Gynecologic Oncology·Martee L HensleyDavid Spriggs
Jun 17, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Clare R BankheadJoan Austoker
Nov 23, 2006·The Journal of Pathology·Y LeeC P Crum
Aug 27, 2009·BMJ : British Medical Journal·William HamiltonDeborah Sharp
Oct 8, 2009·BMJ : British Medical Journal·Graham Wheatley
Dec 16, 2010·BMJ : British Medical Journal·Dirk TimmermanLil Valentin
Feb 9, 2011·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Marian K PittsJudy M Simpson
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Apr 23, 2011·BMJ : British Medical Journal·C RedmanUNKNOWN Guideline Development Group
Sep 24, 2011·Nature Reviews. Cancer·Sebastian VaughanFrances R Balkwill
Jan 20, 2012·The Lancet Oncology·Lucy GilbertUNKNOWN DOvE Study Group
Jul 4, 2012·Gynecologic Oncology·Camille MaringeUNKNOWN ICBP Module 1 Working Group
Feb 21, 2013·BMC Women's Health·Esther L MossHelen Stokes-Lampard
Jan 28, 2014·Obstetrics and Gynecology·M Robyn AndersenBarbara A Goff
Citations
Sep 22, 2018·European Journal of Cancer Care·Brian D NicholsonJason L Oke
Oct 29, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Matthew BarclayAndrew Nordin
Jul 30, 2019·Acta Obstetricia Et Gynecologica Scandinavica·Marie-Louise Ladegaard BaunPeter Vedsted
Dec 1, 2019·Scientific Reports·Henry D ReyesJesus Gonzalez-Bosquet
Oct 18, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mark J A RietveldNicole P M Ezendam
Nov 5, 2019·BMC Cancer·Garth FunstonFiona M Walter
Mar 9, 2019·Molecular and Clinical Oncology·Julie L HentzeEstrid V Høgdall
Jun 8, 2021·Scandinavian Journal of Primary Health Care·Marie-Louise Ladegaard BaunPeter Vedsted